Human Telomerase Reverse-Transcriptase Promoter-Controlled and Herpes Simplex Virus Thymidine Kinase-Armed Adenoviruses for Renal Cell Carcinoma Treatment [Retraction]
OncoTargets and Therapy · 2026-10 · Volume 19 · 1-1
DOI: 10.2147/ott.s665161 ↗Kurz gefasst
Fachartikel in der Zeitschrift OncoTargets and Therapy, 2026-10. Verfasst von Dawei Tian und 5 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tian, D., Sun, Yang, Lei, Ding, & Han, R. (2026). Human Telomerase Reverse-Transcriptase Promoter-Controlled and Herpes Simplex Virus Thymidine Kinase-Armed Adenoviruses for Renal Cell Carcinoma Treatment [Retraction]. OncoTargets and Therapy, Volume 19, 1-1. https://doi.org/10.2147/ott.s665161
Vancouver
Tian D, Sun, Yang, Lei, Ding, Han R. Human Telomerase Reverse-Transcriptase Promoter-Controlled and Herpes Simplex Virus Thymidine Kinase-Armed Adenoviruses for Renal Cell Carcinoma Treatment [Retraction]. OncoTargets and Therapy. 2026;Volume 19:1-1. doi:10.2147/ott.s665161
BibTeX
@article{Tian2026,
author = {Tian, Dawei and Sun and Yang and Lei and Ding and Han, Ruifa},
title = {Human Telomerase Reverse-Transcriptase Promoter-Controlled and Herpes Simplex Virus Thymidine Kinase-Armed Adenoviruses for Renal Cell Carcinoma Treatment [Retraction]},
journal = {OncoTargets and Therapy},
year = {2026},
volume = {Volume 19},
pages = {1--1},
doi = {10.2147/ott.s665161}
}
EUVIMED